24 REAL-WORLD COMPARISON OF TOFACITINIB VERSUS USTEKINUMAB AMONG ULCERATIVE COLITIS PATIENTS WITH PRIOR ANTI-TUMOR NECROSIS FACTOR ALPHA AND ANTI-INTEGRIN TREATMENT FAILURE: A PROPENSITY SCORE-ADJUSTED ANALYSIS
2008 ◽
Vol 103
(2)
◽
pp. 407-415
◽
2012 ◽
Vol 18
(46)
◽
pp. 6819
◽
2007 ◽
Vol 7
(3)
◽
pp. 187-194
◽